Taysha’s $75M offering; Augustine raises €17M

Plus, news about Agile Therapeutics, Insud, Werewolf Therapeutics and Allakos:

Taysha Gene Therapies sells $75M in shares: The biotech is

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Study finds digital CBT for children with anxiety delivers on par with traditional methods, lowers costs

If digitally augmented, therapist-supported, parent-led CBT is a cost-effective and clinically effective alternative.

February 9, 2024

Mainz Biomed Announces Stock Split – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 29.11.2024 / 14:45 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

November 30, 2024

Biden awards $24M to develop mRNA tech targeting cancer, other diseases

The Biden administration’s new biomedical research agency is launching a $24.8 million project to develop mRNA platforms with the goal of using the technology to

August 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.